Clinical Trial: A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895928) titled 'A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors' on March 20.

Brief Summary: The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-A2102 with other antitumor therapies in advanced solid tumors to explore the reasonable dosage, safety and efficacy of SHR-A2102 for advanced solid tumors.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: SHR-A2102

SHR-A2102 for injection.

DRUG: Bevacizumab Injection

Bevacizumab injection.

DRUG: Adebelimab Injection

Adebelimab injection.

DRUG: Ametinib Mesylate Tablets

A...